Valuation Regeneron Pharmaceuticals, Inc. Sao Paulo

Stocks

Market Closed - Sao Paulo 10:07:30 2026-09-11 EDT			5-day change	1st Jan Change
66.50 ^BRL	-1.76%		-5.94%	-6.22%

09-10	Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says	MT
09-09	Regeneron Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:45 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	66,029	77,057	93,403	76,639	79,193	78,036	-	-
Change	-	16.7%	21.21%	-17.95%	3.33%	-1.46%	-	-
Enterprise Value (EV) ¹	56,196	77,057	84,542	70,331	73,294	70,864	67,981	64,443
Change	-	37.12%	9.71%	-16.81%	4.21%	-3.32%	-4.07%	-5.2%
P/E	8.77x	18.9x	25.3x	18.6x	18.6x	18.1x	15.5x	13.7x
PBR	3.56x	3.41x	3.64x	2.62x	2.58x	2.37x	2.08x	1.82x
PEG	-	-0.4x	-2.8x	1.8x	2.27x	4.41x	0.9x	1.1x
Capitalization / Revenue	4.11x	6.33x	7.12x	5.4x	5.52x	4.61x	4.22x	3.95x
EV / Revenue	3.5x	6.33x	6.45x	4.95x	5.11x	4.19x	3.68x	3.26x
EV / EBITDA	5.71x	12.7x	15.2x	12.3x	13.5x	9.84x	9.04x	7.76x
EV / EBIT	6.28x	13.5x	16.5x	13.5x	15x	11.5x	9.53x	8.11x
EV / FCF	8.61x	17.4x	21.8x	19.2x	18x	12x	10.6x	9.08x
FCF Yield	11.6%	5.74%	4.58%	5.21%	5.57%	8.36%	9.46%	11%
Dividend per Share ²	-	-	-	-	3.52	3.902	4.398	4.922
Rate of return	-	-	-	-	0.46%	0.5%	0.56%	0.63%
EPS ²	71.97	38.22	34.77	38.34	41.48	43.18	50.38	56.93
Distribution rate	-	-	-	-	8.49%	9.04%	8.73%	8.64%
Net sales ¹	16,072	12,173	13,117	14,202	14,343	16,927	18,484	19,741
EBITDA ¹	9,835	6,060	5,547	5,695	5,428	7,205	7,518	8,304
EBIT ¹	8,947	5,719	5,126	5,212	4,884	6,157	7,133	7,951
Net income ¹	8,075	4,338	3,954	4,413	4,505	4,773	5,445	6,131
Net Debt ¹	-9,833	-	-8,862	-6,308	-5,899	-7,172	-10,055	-13,592
Reference price ²	631.52	721.49	878.29	712.33	771.87	781.49	781.49	781.49
Nbr of stocks (in thousands)	104,556	106,802	106,347	107,590	102,599	99,855	-	-
Announcement Date	2/4/22	2/3/23	2/2/24	2/4/25	1/30/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.1x	4.19x	9.84x	0.5%	78.02B
CSL LIMITED	19.65x	4.21x	13.08x	2.5%	57.4B
MODERNA, INC.	-17.17x	25.62x	-16.63x	-.--%	57.48B
SAMSUNG BIOLOGICS CO.,LTD.	34.47x	11.73x	22.49x	-.--%	48.81B
UCB	20.54x	4.54x	12.95x	0.71%	45.5B
BIOGEN INC.	37.49x	3.54x	13.51x	-.--%	32.08B
INCYTE CORPORATION	54.21x	3.43x	26.59x	-.--%	24.62B
INNOVENT BIOLOGICS, INC.	62.21x	6.52x	39.5x	-.--%	20.77B
SWEDISH ORPHAN BIOVITRUM AB	22.98x	4.94x	12.86x	-.--%	15.75B
Average	28.05x	7.64x	14.91x	0.41%	42.27B
Weighted average by Cap.	21.98x	8.49x	11.46x	0.56%